Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.58 |
| ▸ | ADH1C | P00326 | 1/20 | 0.58 |
| ▸ | ADH1A | P07327 | 1/20 | 0.58 |
| ▸ | ADH4 | P08319 | 1/20 | 0.58 |
| ▸ | ADH7 | P40394 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL726335 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL3689236 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL277214 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL277135 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4603730 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL1203435 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4660468 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14142731 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL16223598 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2237108 | 1.00 | ADH1B (0.58) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642829-B1 | EPOXIDE-BASED COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-3701064-B1 | A FORMULATION FOR CORROSION INHIBITION | HINDUSTAN PETROLEUM CORP LTD (IN) | 2023-07-19 | — | — | EP | claimed |
| EP-2489344-B1 | Dental material based on an anti-microbial compound | IVOCLAR VIVADENT AG (LI) | 2021-03-24 | — | — | EP | claimed |
| EP-3165561-B1 | RAPID CURING THIOL EPOXY RESIN WITH IMPROVED COMPRESSION STRENGTH PERFORMANCE | BOEING CO (US) | 2021-01-13 | — | — | EP | claimed |
| EP-2852381-B1 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF MAKING AND METHODS OF USING THE SAME | UNIV OHIO STATE (US) | 2020-10-07 | — | — | EP | claimed |
| EP-2551287-B1 | Additive compound which can be used to control foaming properties during the production of polyurethane soft foams containing polyols based on renewable materials | EVONIK DEGUSSA GMBH (DE) | 2019-09-11 | — | — | EP | claimed |
| EP-2601244-B1 | SILICONE COPOLYMERS WITH PENDANT ALKYL RADICALS ATTACHED VIA ALLYL GLYCIDYL ETHER AND RELATED COMPOUNDS, AND USE THEREOF AS STABILIZERS FOR PRODUCTION OF FLEXIBLE POLYURETHANE FOAMS | EVONIK DEGUSSA GMBH (DE) | 2015-05-20 | — | — | EP | claimed |
| EP-1669383-B1 | CATALYST COMPOSITION FOR PRODUCTION OF RIGID POLYURETHANE FOAM AND ISOCYANURATE-MODIFIED RIGID POLYURETHANE FOAM AND RAW-MATERIAL COMPOSITION CONTAINING THE SAME | TOSOH CORP (JP) | 2014-11-12 | — | — | EP | claimed |
| EP-2601244-A1 | SILICONE COPOLYMERS WITH PENDANT ALKYL RADICALS ATTACHED VIA ALLYL GLYCIDYL ETHER AND RELATED COMPOUNDS, AND USE THEREOF AS STABILIZERS FOR PRODUCTION OF FLEXIBLE POLYURETHANE FOAMS | Evonik Goldschmidt GmbH (DE) | 2013-06-12 | — | — | EP | claimed |
| EP-2551287-A2 | Additive compound which can be used to control foaming properties during the production of polyurethane soft foams containing polyols based on renewable materials | Evonik Goldschmidt GmbH (DE) | 2013-01-30 | — | — | EP | claimed |
| US-20120208917-A1 | Dental restorative material based on an antimicrobially active compound | IVOCLAR VIVADENT AG (LI) | 2012-08-16 | — | — | US | claimed |
| WO-2012016776-A1 | SILICONE COPOLYMERS WITH PENDANT ALKYL RADICALS ATTACHED VIA ALLYL GLYCIDYL ETHER AND RELATED COMPOUNDS, AND USE THEREOF AS STABILIZERS FOR PRODUCTION OF FLEXIBLE POLYURETHANE FOAMS | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-02-09 | — | — | WO | claimed |
| EP-1353989-B1 | HALOGENATED ELASTOMERIC COMPOSITIONS HAVING IMPROVED STABILITY AND GREEN STRENGTH | EXXONMOBIL CHEM PATENTS INC (US) | 2009-09-09 | — | — | EP | claimed |
| EP-1660062-B1 | USE OF COLIPASE-LIPASE INHIBITORS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION IN ORDER TO PREVENT OBESITY | FORSKARPATENT I SYD AB (SE) | 2008-07-09 | — | — | EP | claimed |
| EP-1171222-B1 | PROCESS FOR REMOVING HYDROGEN SULFIDE FROM GASES | CRYSTATECH INC (US) | 2004-09-01 | — | — | EP | claimed |
| EP-0276501-B2 | Thickening compositions and thickened aqueous acid solutions | AKZO NOBEL NV (NL) | 1998-06-17 | — | — | EP | claimed |
| EP-0217197-B1 | DETERMINATION OF BILIRUBIN AND CORRESPONDING REAGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 1991-10-16 | — | — | EP | claimed |
| EP-0217197-A2 | Determination of bilirubin and corresponding reagents | F. HOFFMANN-LA ROCHE AG (CH) | 1987-04-08 | — | — | EP | claimed |
| EP-4190882-B1 | QUATERNISED NITROGEN COMPOUNDS SUBSTITUTED WITH HYDROCARBYL-POLYCARBOXYLIC ACID AND ALKYLENE OXIDE AS ADDITIVES IN FUELS | BASF SE (DE) | 2024-12-25 | — | — | EP | disclosed |
| EP-0176059-A2 | Process for the manufacture of laking products with improved application properties | BASF Aktiengesellschaft (DE) | 1986-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208917-A1 | Dental restorative material based on an antimicrobially active compound | COL1A1, COL2A1, COL14A1 | ADH1B 3776/4885ADH1C 3817/4885ADH1A 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.